Publishing policies

  • HOME
  • Publishing policies
Editorial policies:
It aims at providing medical information to physicians, medical health personnel, general people in order to prevent diseases of public health importance and to improve health and quality of life of the people. It adheres completely to guidelines and best practices published by professional organizations, including Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals ( from ICMJE and Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA; ( . All books or reports published is freely available and not for commercial purpose. Manuscripts were invited by the editor based on the request of member of Korean Medical Association and general people.

Peer review policy: All submitted manuscripts are peer-reviewed although they are commissioned one. Single blind peer review is adopted. Before reviewing, all submitted manuscripts are inspected by Similarity Check powered by iThenticate (, a plagiarism-screening tool. Manuscripts are then peer reviewed by at least 2 or more experts in the corresponding field.

The review period is 2 weeks. Usually the first decision is made within a week after completion of the review. The Editorial Board’s decision after the review will be one of followings: Accept, Minor revision, Major revision, or Rejection. The Editorial Board may request the authors to revise the manuscript according to the reviewers’ comments. If there are any requests for revision of the manuscript by the reviewers, the authors should do their best to revise the manuscript. If the reviewer's opinion is not acceptable or is believed to misinterpret the data, the author should reasonably indicate that. After revising the manuscript, the author should dispatch the revised files with a reply to each item of the reviewer's commentary. The author's revisions should be completed within 30 days after the request. If it is not received by the due date, the Editorial Board will notify the author. To extend the revision period beyond 30 days, the author should negotiate that with the Editorial Board. The manuscript review process can be provided for up two rounds. If the authors wish further review, the Editorial Board may consider it. The Editorial Board will make a final decision on the approval of the submitted manuscript for publication and can request any further corrections, revisions, and deletions of the article text if necessary. Statistical editing is also performed if the data requires professional statistical review by a statistician.
Advertising policy:
It does not accept any commercial product advertisements until policy changes otherwise. Although any commercial products are included in the text, it does not mean KMA guarantee those products. It is just for the information. For specific clinical care, authors should visit their physicians.

Policy on Conflict of Interest, Human and Animal Rights, and Informed Consent for publications:
Conflict-of-Interest statement

Conflict of interest exists when an author or the author’s institution, reviewer, or editor has financial or personal relationships that inappropriately influence or bias his or her actions. Such relationships are also known as dual commitments, competing interests, or competing loyalties. These relationships vary from being negligible to having a great potential for influencing judgment. Not all relationships represent true conflict of interest. On the other hand, the potential for conflict of interest can exist regardless of whether an individual believes that the relationship affects his or her scientific judgment. Financial relationships such as employment, consultancies, stock ownership, honoraria, and paid expert testimony are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, or of the science itself. Conflicts can occur for other reasons as well, such as personal relationships, academic competition, and intellectual passion ( If there are any conflicts of interest, authors should disclose them in the manuscript. The conflicts of interest may occur during the research process as well; however, it is important to provide disclosure. If there is a disclosure, editors, reviewers, and reader can approach the manuscript after understanding the situation and the background of the completed research.

Statement of human and animal rights

For the clinical studies with human subjects, there should be a certificate, an agreement, or the approval by the Institutional Review Board (IRB) of the author's affiliated institution. If necessary, the editor or reviewers may request copies of these documents to resolve questions about IRB approval and study conduct. For animal subjects, research should be performed based on the National or Institutional Guide for the Care and Use of Laboratory Animals, and the ethical treatment of all experimental animals should be maintained.

Informed Consent

Copies of written informed consents should be kept for studies on human subjects

The role of acquisitions editors and editorial boards in reviewing and approving material that is published:
For review process, although manuscripts are reviewed by outside specialists, editorial board reviews the manuscripts for their fitness to both aims and scope and style and format at first. If manuscript does not fit them, it was returned to authors for revision before review.

During the publication process, editorial board decides the finally the fate of the manuscripts. If revision is required, the comments are dispatched to authors. After confirming the coherence of the manuscript to scientific and ethical standards, they are accepted. After acceptance, the manuscripts are sent to manuscript editors and English proof-readers (for English writing, if necessary). All publication procedures are directed by the Editorial board.

The process for handling cases requiring corrections, retractions, and editorial expressions of concern:

When the Editorial board faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem discovered with the submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editor and other issues, the resolving process will follow the flowchart provided by the Committee on Publication Ethics ( The Editorial board will discuss the suspected cases and reach a decision. Editorial board will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.